Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma

Systemic monotherapy with rituximab is a well-known treatment approach for primary cutaneous follicle centre lymphoma and primary cutaneous marginal zone lymphoma. Both have excellent prognosis despite high relapse rates. To investigate the long-term effectiveness and clinical outcome of intravenous...

Descripción completa

Detalles Bibliográficos
Autores principales: PORKERT, Stefanie, MAI, Pamela, JONAK, Constanze, WEIHSENGRUBER, Felix, RAPPERSBERGER, Klemens, BAUER, Wolfgang, SIMONITSCH-KLUPP, Ingrid, RADERER, Markus, VALENCAK, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Publication of Acta Dermato-Venereologica 2021
Materias:
Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366677/
https://www.ncbi.nlm.nih.gov/pubmed/33475146
http://dx.doi.org/10.2340/00015555-3746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366677/
https://www.ncbi.nlm.nih.gov/pubmed/33475146
http://dx.doi.org/10.2340/00015555-3746

Ejemplares similares